Literature DB >> 12806577

Treatment of post-traumatic tibial osteomyelitis using microsurgical flaps.

Arnaldo V Zumiotti1, Hsiang Wei Teng, Marcus C Ferreira.   

Abstract

Between 1994 and 1998, the authors treated 70 patients presenting with post-traumatic tibial osteomyelitis. Eighty-five percent were males, with a mean patient age of 32 years. The mean duration of the disease was 2 years. Fifty-one percent were of type IV in the Cierny-Mader classification. The mean follow-up period was 36 months. Case management was through thorough debridement, antibiotic therapy, and soft-tissue reconstruction using free flaps: latissimus dorsi (39.4 percent), scapular (28.2 percent), lateral arm (19.7 percent), and anterior serratus (12.7 percent). To evaluate the results, the control of infection and the quality of the soft tissue repaired were considered. The success rate was 90 percent. The authors conclude that their described method constitutes an effective treatment for post-traumatic tibial osteomyelitis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12806577     DOI: 10.1055/s-2003-39829

Source DB:  PubMed          Journal:  J Reconstr Microsurg        ISSN: 0743-684X            Impact factor:   2.873


  3 in total

1.  Latissimus dorsi free flap salvage of recurrent chronic osteomyelitis with simultaneous elbow interposition arthroplasty.

Authors:  Mark Henry
Journal:  Hand (N Y)       Date:  2007-07-14

2.  Insights into treatment and outcome of fracture-related infection: a systematic literature review.

Authors:  H Bezstarosti; E M M Van Lieshout; L W Voskamp; K Kortram; W Obremskey; M A McNally; W J Metsemakers; M H J Verhofstad
Journal:  Arch Orthop Trauma Surg       Date:  2018-10-20       Impact factor: 3.067

3.  Single-stage treatment of chronic localized tibial osteomyelitis with local debridement and antibiotic-loaded calcium sulfate implantation: a retrospective study of 42 patients.

Authors:  Chun-Hao Zhou; Ying Ren; Abdulnassir Ali; Xiang-Qing Meng; Hong-An Zhang; Jia Fang; Cheng-He Qin
Journal:  J Orthop Surg Res       Date:  2020-06-01       Impact factor: 2.359

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.